This year’s data draw has been completed – thanks for the outstanding commitment of everyone involved!
At the same time, please note that the questionnaire version has been updated; the current version is now V9.2.
Our 8th International Anaphylaxis Conference will take place on March 28th and 29th. We look forward to an interactive exchange!
Status: Wednesday, 07. May 2025
14265 completed cases
| Male patients | 6684 | 47% |
| Female patients | 7581 | 53% |
| Children and youths | 3393 | 24% |
| Adults | 10872 | 76% |
completed cases per country:
| Germany | 10531 | 74% |
| Austria | 1187 | 8% |
| Switzerland | 2547 | 18% |
2666 completed cases
| Male patients | 1436 | 54% |
| Female patients | 1230 | 46% |
| Children and youths | 1085 | 41% |
| Adults | 1581 | 59% |
3557 completed cases
| Male patients | 1986 | 56% |
| Female patients | 1571 | 44% |
| Children and youths | 1406 | 40% |
| Adults | 2151 | 60% |
completed cases per country:
| Brazil | 267 | 8% |
| Bulgaria | 256 | 7% |
| Greece | 425 | 12% |
| Ireland | 240 | 7% |
| Italy | 962 | 27% |
| Poland | 558 | 16% |
| Spain | 664 | 19% |
| Romania | 77 | 2% |
| Netherlands | 81 | 2% |
| Croatia | 27 | 1% |
347 completed cases
| Male patients | 189 | 54% |
| Female patients | 158 | 46% |
| Children and youths | 305 | 88% |
| Adults | 42 | 12% |
